NZ707930A - Dual inhibitors of met and vegf for the treatment of castration-resistant prostate cancer and osteoblastic bone metastases - Google Patents
Dual inhibitors of met and vegf for the treatment of castration-resistant prostate cancer and osteoblastic bone metastasesInfo
- Publication number
- NZ707930A NZ707930A NZ707930A NZ70793011A NZ707930A NZ 707930 A NZ707930 A NZ 707930A NZ 707930 A NZ707930 A NZ 707930A NZ 70793011 A NZ70793011 A NZ 70793011A NZ 707930 A NZ707930 A NZ 707930A
- Authority
- NZ
- New Zealand
- Prior art keywords
- prostate cancer
- vegf
- castration
- met
- treatment
- Prior art date
Links
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38695910P | 2010-09-27 | 2010-09-27 | |
US201161481671P | 2011-05-02 | 2011-05-02 | |
NZ60921211 | 2011-09-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ707930A true NZ707930A (en) | 2016-09-30 |
Family
ID=56989724
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ707930A NZ707930A (en) | 2010-09-27 | 2011-09-26 | Dual inhibitors of met and vegf for the treatment of castration-resistant prostate cancer and osteoblastic bone metastases |
Country Status (1)
Country | Link |
---|---|
NZ (1) | NZ707930A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2694259C2 (en) * | 2017-10-16 | 2019-07-11 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Кировский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Кировский ГМУ Минздрава России) | Method of castration-resistant prostate cancer treatment |
RU2700573C2 (en) * | 2017-10-16 | 2019-09-18 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Кировский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Кировский ГМУ Минздрава России) | Method of castration-resistant prostate cancer treatment |
-
2011
- 2011-09-26 NZ NZ707930A patent/NZ707930A/en unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2694259C2 (en) * | 2017-10-16 | 2019-07-11 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Кировский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Кировский ГМУ Минздрава России) | Method of castration-resistant prostate cancer treatment |
RU2700573C2 (en) * | 2017-10-16 | 2019-09-18 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Кировский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Кировский ГМУ Минздрава России) | Method of castration-resistant prostate cancer treatment |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX352926B (en) | Dual inhibitors of met and vegf for the treatment of castration- resistant prostate cancer and osteoblastic bone metastases. | |
PH12014502047B1 (en) | Treatment of cancer with tor kinase inhibitors | |
MX2015007205A (en) | Histone demethylase inhibitors. | |
CR20120202A (en) | METHODS AND COMPOSITIONS TO TREAT CANCER | |
WO2013177187A3 (en) | Synergistic tumor treatment with extended-pk il-2 and therapeutic agents | |
AU2011328009A8 (en) | Compounds and methods for treating pain | |
EA201490944A1 (en) | DOUBLE MET AND VEGF INHIBITOR FOR CANCER TREATMENT | |
IN2014DN08812A (en) | ||
WO2013056148A3 (en) | Scd1 antagonists for treating cancer | |
MX343135B (en) | Fumagillol type compounds and methods of making and using same. | |
MX2015014046A (en) | Drug combinations to treat cancer. | |
TN2013000227A1 (en) | Use of sigma ligands in bone cancer pain | |
AU2013225816A8 (en) | Compositions and methods for treating Type III Gaucher Disease | |
PH12015502342B1 (en) | Combination therapy comprising a dihydropyrazino-pyrazine compound and an androgen receptor antagonist for treating prostate cancer | |
EA201890598A3 (en) | ANTIANDROGENS FOR THE TREATMENT OF NON-METASTATIC CASTRATION RESISTANT CANCER OF THE PROSTATE | |
PH12015500867B1 (en) | Treatment of prostate cancer with tor kinase inhibitors | |
GB201302343D0 (en) | Pharmaceutical compositions comprising 15-OHEPA and methods for using the same | |
SG191060A1 (en) | Robo1-fc fusion protein for use in the treatment of hepatocarcinoma | |
WO2013106460A3 (en) | Compositions and methods for treating malignant astrocytomas | |
WO2011130692A3 (en) | Androgen induced oxidative stress inhibitors | |
WO2011130697A3 (en) | Tissue targeting | |
NZ707930A (en) | Dual inhibitors of met and vegf for the treatment of castration-resistant prostate cancer and osteoblastic bone metastases | |
MX350868B (en) | MEDICAMENTS and METHODS FOR TREATING CANCER. | |
EP2575766A4 (en) | Novel pharmaceutical compounds | |
TN2010000463A1 (en) | Compositions and methods for preparing and using same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 26 SEP 2018 BY AJ PARK Effective date: 20170426 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2019 BY CPA GLOBAL Effective date: 20180816 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2020 BY CPA GLOBAL Effective date: 20190815 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2021 BY CPA GLOBAL Effective date: 20200813 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2022 BY CPA GLOBAL Effective date: 20210812 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2023 BY CPA GLOBAL Effective date: 20220811 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2024 BY CPA GLOBAL Effective date: 20230811 |